FDA Inspection 1280335 — Hubei Haosun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Haosun Pharmaceutical Co., Ltd. on Aug 1, 2025 in Ezhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)